Efficacy of Genicular Nerve Alcohol Neurolysis in Knee Osteoarthritis Pain

Sponsor

Diskapi Teaching and Research Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT06060678

Collaborator

(none)

Enrollment

Location

1.8

Actual Duration (Months)

28.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aimed to evaluate the efficacy of genicular nerve alcohol neurolysis in the treatment of pain caused by chronic knee osteoarthritis. The investigators will evaluate the efficacy of genicular nerve alcohol neurolysis using the numeric rating scale (NRS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) through patients' medical records. NRS and WOMAC scores will be evaluated before, 1, and 3 months after the procedure.

Condition or Disease	Intervention/Treatment	Phase
Knee Pain Chronic

Detailed Description

Alcohol neurolysis of the genicular nerve is a procedure that involves injecting alcohol around the nerve branches that supply sensation to the knee joint. The alcohol destroys the nerve fibers and blocks the transmission of pain signals from the knee to the brain. This technique can be used to treat chronic knee pain caused by osteoarthritis (OA).

Several studies have reported that alcohol neurolysis of the genicular nerve can provide significant pain relief and functional improvement in patients with knee OA or postoperative pain. For example, Dass et al. (1) reported two cases of alcohol neurolysis of the genicular nerve using fluoroscopy and ultrasonography in patients with knee OA or persistent postsurgical pain of the knee. Both patients had more than 50% reduction in their numerical rating scale (NRS) scores and improved range of motion and quality of life at 3 months follow-up.

Ultrasonography-guided genicular nerve alcohol neurolysis is prominent with its easy applicability and low cost. There are no studies in the literature evaluating the efficacy of genicular nerve alcohol neurolysis for chronic knee OA. In this retrospective study, the investigators will evaluate the NRS and WOMAC scores of patients who underwent genicular nerve alcohol neurolysis for chronic knee OA before, 1, and 3 months after the procedure. In addition, the incidence of procedure-related adverse events (such as paresthesia) recorded in patient records will be analyzed.

Dass RM et al. Alcohol neurolysis of genicular nerve for chronic knee pain. Korean J Pain 2019; 32 (3): 223-227. https://www.epain.org/journal/view.html?doi=10.3344/kjp.2019.32.3.223

Study Design

Study Type:

Observational

Actual Enrollment :

51 participants

Observational Model:

Other

Time Perspective:

Retrospective

Official Title:

Evaluation of the Efficacy of Genicular Nerve Alcohol Neurolysis in the Management of Knee Osteoarthritis Pain

Actual Study Start Date :

Jul 28, 2023

Actual Primary Completion Date :

Sep 15, 2023

Actual Study Completion Date :

Sep 20, 2023

Outcome Measures

Primary Outcome Measures

Numeric rating scale (NRS) [Change from Baseline NRS at 1 and 3 months]
Patients are asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that fits best to their pain intensity.

Secondary Outcome Measures

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) [Change from Baseline WOMAC at 1 and 3 months]
The WOMAC Pain score ranges from 0 to 20 with higher scores equating to greater pain with activities of daily living. The generic pain scale ranges from 0 to 10 for the OAI and 0 to 100 for MOST, with higher scores equating to greater pain

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Moderate to severe knee pain due to knee osteoarthritis (0-10 pain of intensity 6 and above on an inter-numeric pain scale)
Permanent pain for more than 6 months
Grade 3 or 4 in the radiological Kellgren-Lawrence classification having osteoarthritis
Pain with conservative methods such as analgesics and physiotherapy treatment failure